Status:
COMPLETED
Comparison of Two Different Natural Surfactants in the Treatment of Pulmonary Hemorrhage
Lead Sponsor:
Dr. Sami Ulus Children's Hospital
Conditions:
Pulmonary Hemorrhage
Eligibility:
All Genders
1-1 years
Phase:
NA
Brief Summary
The incidence of pulmonary hemorrhage (PH) was about 1.3 per 1,000 live births. PH occurs mainly in preterm ventilated infants with severe respiratory distress syndrome (RDS) who often have a PDA and ...
Detailed Description
The incidence of PH was about 1.3 per 1,000 live births. Formerly,the risk factors associated with PH included the severity of the associated illness, intrauterine growth restriction, patent ductus ar...
Eligibility Criteria
Inclusion
- Premature infants \<1500 g
- Within first week of life
Exclusion
- Major congenital abnormalities
- Without parental consent
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2011
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01860014
Start Date
March 1 2010
End Date
March 1 2011
Last Update
May 22 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zekai Tahir Burak Hospital
Ankara, Turkey (Türkiye), 06120